Eliseo Guallar

Chair and Professor of the Department of Epidemiology

Professional overview

Dr. Guallar is an epidemiologist whose research is focused on the study of cardiovascular disease epidemiology and prevention, with an emphasis on evaluating the role of environmental and nutritional exposures in the development of cardiovascular disease. This research has made critically important and novel contributions to our understanding of risk factors for chronic disease both in the US and globally. He has published seminal articles and is a leading figure in an emerging field highlighting the risks of exposure to levels of metals previously considered safe for cardiovascular health. In addition to his work in toxic metals, Dr. Guallar has made important contributions to understanding the effects of certain micronutrients and vitamin supplements on cardiovascular disease risk and outcomes. Publications in this area were influential in changing consumer habits and attitudes towards these products. Much of this research has been funded by the National Institutes of Health, the Agency for Healthcare Research and Quality, the American Heart Association, the CDC, and other funders.

Dr. Guallar was the founding director of the Center for Clinical Epidemiology at the Samsung Medical Center and a lead investigator of the Kangbuk Samsung Cohort Study at the Kangbuk Samsung Hospital since its inception in 2010. Dr. Guallar has published over 500 research papers in peer-reviewed journals. He is also a Deputy Editor for Methods at the Annals of Internal Medicine and a past member and Chair of the Cancer, Heart, and Sleep Study Section at the National Institutes of Health.

Prior to teaching at NYU, Dr. Guallar was a Professor of Epidemiology and Medicine at the Johns Hopkins University Bloomberg School of Public Health and a core faculty member of the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins. In the Department of Epidemiology, Dr. Guallar was the Director of the Environmental and Occupational Area of Concentration and the Co-Director of the PhD Program. Dr. Guallar was also an adjunct Professor at the Department of Clinical Research Design and Evaluation of the Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, in Seoul, Korea.

Education

Diploma of English, Spanish Official School of Languages at Zaragoza (Escuela Oficial de Idiomas de Zaragoza), Zaragoza, Spain

MD, University of Zaragoza, Zaragoza, Spain

MPH, University of Minnesota, Minneapolis, MN

DrPH, Harvard University, Boston, MA

Honors and awards

Six Honor Calls in the MD Program, University of Zaragoza School of Medicine (1981)

Fellow of Spain’s Program of Training of Graduate Research of the Ministry of Education and Science, University of Zaragoza (1988)

Fulbright Scholar, sponsored by Spain’s Ministry of Health and Consumer Affairs (1989)

Faculty Innovation Award, Johns Hopkins University Bloomberg School of Public Health (2001)

Scientist Development Award, American Heart Association (2002)

Fellow of the American Heart Association, Council on Epidemiology and Prevention (2013)

Advising, Mentoring, and Teaching Recognition Award 2014 – 2015, Johns Hopkins University Bloomberg School of Public Health (2015)

High Impact Research Icon, University of Malaya (2015)

Publications

Publications

Mercury and the risk of myocardial infarction [3] (multiple letters)

Meta-Analysis of Randomized Educational and Behavioral Interventions in Type 2 Diabetes

Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States

Systolic Blood Pressure, Diastolic Blood Pressure, and Pulse Pressure: An Evaluation of Their Joint Effect on Mortality

Transition models for change-point estimation in logistic regression

Mercury, fish oils, and the risk of myocardial infarction

Receipt of preventive medical services at psychiatric visits by patients with severe mental illness

The effect of magnesium supplementation on blood pressure: A meta-analysis of randomized clinical trials

Utility of blood pressure monitoring outside of the clinic setting.

Utility of whole blood hemostatometry using The Clot Signature Analyzer® for assessment of hemostasis in cardiac surgery

Autologous blood transfusion in the United States: Clinical and nonclinical determinants of use

Re: "Use of two-segmented logistic regression to estimate change-points in epidemiologic studies" [1]

Relationship between systemic markers of inflammation and serum β-carotene levels

Statins and cancer: A case of meta-uncertainty

Does peer review predict the performance of research projects in health sciences?

Cost-benefit analysis of Haemophilus influenzae type b vaccination in children in Spain

Determinants of p, p'-Dichlorodiphenyldichloroethane (DDE) Concentration in Adipose Tissue in Women from Five European Cities

Ecuestas alimentarias en los niños españoles de edad escolar: Análisis del período 1984-1994

Omega-3 fatty acids in adipose tissue and risk of myocardial infarction: The EURAMIC study

El placebo en ensayos clinicos con medicamentos

Previous disability as a predictor of outcome in a geriatric rehabilitation unit

Use of two-segmented logistic regression to estimate change-points in epidemiologic studies

A graphical display useful for meta-analysis

Alcohol intake and risk of breast cancer: The euramic study

Cerebrovascular disease mortality in Spain, 1955-1992: An age-period-cohort analysis